Sleep

The Pharmacy Times® Sleep Resource Center is a comprehensive resource for clinical news and expert insights on issues related to sleep disorders, including insomnia, restless legs syndrome, narcolepsy, and sleep apnea.

Clinical Overview: Serotonin Syndrome

May 12, 2022

Article

Serotonin syndrome generally occurs within 6 hours of a change in dose or addition of medication.

Clinical Overview: Daridorexant for the Treatment of Insomnia

May 03, 2022

Article

The FDA approved daridorexant in January 2022 to treat insomnia after it showed improvements in changes in latency to persistent sleep and wake after sleep onset.

Avadel Pharmaceuticals Announces Interim Data for FT218 as Once-Nightly Dose

April 28, 2022

Article

FT218 is an investigational formulation of sodium oxybate that is designed to be taken once at bedtime for the treatment of excessive daytime sleepiness for individuals with narcolepsy.

Avadel Announces Positive Secondary Endpoint Results for FT218 to Treat Narcolepsy

April 08, 2022

Article

Phase 3 REST-ON Trial data show that the medication demonstrated clinically meaningful improvement in assessments of disrupted nighttime sleep compared with the placebo.

Daily OTC Pearl: Sleep-Aid

April 06, 2022

Article

OTC sleep aids may help treat an occasional sleepless night.

Help Patients Prevent and Reduce Insomnia

March 15, 2022

Article

Sleeplessness Is prevalent, and many Individuals struggle to find effective relief and treatment.

Daily Medication Pearl: Suvorexant (Belsomra)

March 02, 2022

Article

Suvorexant (Belsomra) is indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

The Role of Daridorexant in the Treatment of Insomnia

February 18, 2022

Article

Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.

Study: Sleep Apnea During Pregnancy Is Linked to Risk of Hypertension, Metabolic Syndrome

February 16, 2022

Article

Those with the disorder during gestation and who were examined 2 to 7-years after delivery had a more than 3-fold increased risk for incident high blood pressure, results of the analysis show.

Study: Common Sleep Apnea Treatment May Not Benefit Patients Older Than 80 Years of Age

February 14, 2022

Article

Prior studies indicate that CPAP treatment can significantly decrease sleepiness and depression while also protecting against high blood pressure.